Anifrolumab in lupus: the promise and the caution - Author's reply

Lancet Rheumatol. 2020 Aug;2(8):e462. doi: 10.1016/S2665-9913(20)30218-6. Epub 2020 Jul 29.

Author

Richard Furie¹

Affiliation

¹ Division of Rheumatology, Zucker School of Medicine at Hofstra/Northwell Health, Great Neck, NY 11021, USA. Electronic address: rfurie@northwell.edu.

PMID: 38273609
DOI: 10.1016/S2665-9913(20)30218-6

No abstract available

Publication types

Letter